US › Healthcare

Apollomics Inc. Class A Ordinary Shares (APLM)

US · Healthcare · Biotechnology

$22.52+1.90%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Net profit

$1.6M

EPS

$-11.37

EPS estimate

$0.00

Key statistics

Market cap

$67.6M

Forward P/E

0.0

P/B

8.12

Book value

$-1.49

EPS (TTM)

$-7.57

52-week high

$40.02

52-week low

$6.94

50-day MA

$20.96

200-day MA

$18.16

Beta

1.53

Analyst view

Analysts rate Apollomics Inc. Class A Ordinary Shares a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

55.86%

Institutions

0.42%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.50%
Citigroup Inc	0.02%
UBS Group AG	0.01%
SBI Securities Co Ltd	0.00%
BlackRock Inc	0.00%
Kestra Advisory Services, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apollomics Inc. Class A Ordinary Shares — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.